Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;25(2):e113-e119.
doi: 10.3747/co.25.3888. Epub 2018 Apr 30.

Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer

S Chae  1 , K M Kang  1 , H J Kim  1 , E Kang  1 , S Y Park  2 , J H Kim  3 , S H Kim  3 , S W Kim  4 , E K Kim  1
Affiliations

Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer

S Chae et al. Curr Oncol. 2018 Apr.

Abstract

Background: The neutrophil-lymphocyte ratio (nlr) has been reported to correlate with patient outcome in several cancers, including breast cancer. We evaluated whether the nlr can be a predictive factor for pathologic complete response (pcr) after neoadjuvant chemotherapy (nac) in patients with triple-negative breast cancer (tnbc).

Methods: We analyzed the correlation between response to nac and various factors, including the nlr, in 87 patients with tnbc who underwent nac. In addition, we analyzed the association between the nlr and recurrence-free survival (rfs) in patients with tnbc.

Results: Of the 87 patients, 25 (28.7%) achieved a pcr. A high Ki-67 index and a low nlr were significantly associated with pcr. The pcr rate was higher in patients having a high Ki-67 index (≥15%) than in those having a low Ki-67 index (35.7% vs. 0%, p = 0.002) and higher in patients having a low nlr (≤1.7) than in those having a high nlr (42.1% vs. 18.4%, p = 0.018). In multiple logistic analysis, a low nlr remained the only predictive factor for pcr (odds ratio: 4.274; p = 0.008). In the survival analysis, the rfs was significantly higher in the low nlr group than in the high nlr group (5-year rfs rate: 83.7% vs. 66.9%; log-rank p = 0.016).

Conclusions: Our findings that the nlr is a predictor of pcr to nac and also a prognosticator of recurrence suggest an association between response to chemotherapy and inflammation in patients with tnbc. The pretreatment nlr can be a useful predictive and prognostic marker in patients with tnbc scheduled for nac.

Keywords: Triple-negative breast cancer; neoadjuvant chemotherapy; neutrophil–lymphocyte ratio; pathologic complete response; recurrence-free survival.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Study population selection. TNBC = triple-negative breast cancer.
FIGURE 2
FIGURE 2
Recurrence-free survival by (A) neutrophil–lymphocyte ratio (NLR) and by (B) pathologic complete response (pCR). NAC = neoadjuvant chemotherapy.
See this image and copyright information in PMC

References

    1. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–74. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003;100:10393–8. doi: 10.1073/pnas.1732912100. - DOI - PMC - PubMed
    1. Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur j Cancer. 2009;45(suppl 1):27–40. doi: 10.1016/S0959-8049(09)70013-9. - DOI - PubMed
    1. Gluz O, Liedtke C, Gottschalk N, Pusztai L, Nitz U, Harbeck N. Triple-negative breast cancer—current status and future directions. Ann Oncol. 2009;20:1913–27. doi: 10.1093/annonc/mdp492. - DOI - PubMed
    1. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;30:96–102. doi: 10.1093/oxfordjournals.jncimonographs.a003469. - DOI - PubMed

Publication types

MeSH terms

Substances